Angiogenesis and its targeting in rheumatoid arthritis
- 13 February 2009
- journal article
- review article
- Published by Elsevier in Vascular Pharmacology
- Vol. 51 (1) , 1-7
- https://doi.org/10.1016/j.vph.2009.02.002
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Differential expression of the FAK family kinases in rheumatoid arthritis and osteoarthritis synovial tissuesArthritis Research & Therapy, 2007
- The ITGAVrs3738919-C allele is associated with rheumatoid arthritis in the European Caucasian population: a family-based studyArthritis Research & Therapy, 2007
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathwayPublished by Elsevier ,2007
- Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritisArthritis Research & Therapy, 2007
- Association of ITGAV supports a role of angiogenesis in rheumatoid arthritisArthritis Research & Therapy, 2007
- Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosisArthritis Research & Therapy, 2007
- Effect of interleukin-4 on vascular endothelial growth factor production in rheumatoid synovial fibroblastsClinical and Experimental Immunology, 2006
- Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapyJournal of the American Academy of Dermatology, 2006
- Thalidomide is an inhibitor of angiogenesis.Proceedings of the National Academy of Sciences, 1994